Dr. Allen is the Medical Director of Rushford Center, Chief of Psychiatry at Midstate Medical Center, and Vice President of Addiction Services for the Behavioral Health Network of Hartford Healthcare. Dr. Allen is on the state of Connecticut’s Alcohol and Drug Policy Council co-chairing the treatment subcommittee; on the Advisory Board for the Department of Mental Health and Addiction Services, and for the State Medical Society serves on the Addiction Medicine Committee and Opioid Task Force. Dr. Allen has held faculty appointments at Harvard and Yale Medical schools and is currently an Assistant Professor of Psychiatry at the University of Connecticut School of Medicine and Associate Professor of Psychiatry at Quinnipiac University, Frank Netter School of Medicine. In addition, Dr. Allen trains Addiction Medicine fellows in Rushford’s ACGME accredited Addiction Medicine fellowship program, and Child and Adolescent Psychiatry Fellows and Psychiatry Residents from Hartford Hospital’s Institute of Living. Dr. Allen lectures and advocates locally and nationally for prevention, screening, early intervention and treatment access for Substance use and other Psychiatric disorders throughout the lifespan. He is board certified in Addiction Medicine and Child, Adolescent and Adult Psychiatry and see’s patients at Rushford and through his private practice in Branford, CT.

Dr. Henry Conter is solving the impossible problems in healthcare by re-imagining how all types of people can take control of their care and maximize their experience and outcomes. He is a Strategic Health Care Partner at Hoffmann-La Roche, designing patient-focused healthcare solutions that matter to them. He continues as a practicing medical oncologist/hematologist at William Osler Health System and an adjunct professor at the University of Western Ontario, Schulich School of Medicine & Dentistry. Prior to joining Roche, Dr. Conter has a track record for innovation and excellence in leadership as Medical Director of the Cancer Health System, and Executive Medical Director of Quality, Patient Safety, and Health System integration at Osler. He served as a voting member on the Ontario Steering Committee for Cancer Drugs and a member of the pan-Canadian Oncology Drug Review (pCODR) Expert Review Panel and CADTHs national Pharmacare Advisory Panel as the oncology representative. Previously he served on pCODR’s Economic Guidance Panels and Clinical Guidance Panels. Dr. Conter completed his undergraduate degree in mechanical engineering at the University of Western Ontario in 2007. He graduated from McMaster School of Medicine in 2008. He then went to the University of Alberta where he completed his clinical residency in internal medicine in 2011, and received his MSc in health technology assessment in 2012. He completed his clinical fellowship in medical oncology at the University of Texas M.D. Anderson Cancer Center in Houston Texas, and a Masters in Finance at the University of Houston in 2013

Glynne joined the Canadian Armed Forces in 1970 as a gunner in the 56th Field Regiment, Royal Canadian Artillery in Brantford Ontario. Before transferring to the regular forces in 1973, he had qualified and served as a crew commander of a 105mm howitzer crew. Upon transfer to the regular forces, he underwent training as a MARS (Maritime Surface and Sub-surface) officer. He served onboard destroyers and minesweepers while under training and served operationally onboard HMCS Yukon and HMCS Protecteur before volunteering for submarine service. Once qualified in submarines, Glynne served as HMCS Okanagan’s Electrical Officer and HMCS Onondaga’s Engineering Officer before transferring to the Naval Reserves in 1980 where he served with HMCS Hunter in Windsor Ontario. Glynne returned to the regular forces as a CELE (Communications and Electronics Engineering) officer in 1982. During his career as a CELE officer, he served in Kingston Ontario, Elmendorf Alaska, Winnipeg Manitoba, Baden Germany, Goose Bay Labrador, and of course, Ottawa. He commanded Communication Squadron Baden, 73 Communication Group, and 5 Wing/CFB Goose Bay. In addition to his operational deployments with the Navy, he deployed in the first Gulf War as Communications Commander, Canadian Air Task Group Middle East (OP SCIMITAR) and to Sarajevo as Chief, Combined and Joint Communications (CJ6) NATO Stabilization Force (SFOR). Prior to his retirement, his final Canadian posting was as the Chief of Staff (Information Management) and Canadian Forces CJ6 before assuming duties as the Director of Consultation, Command and Control at NATO Headquarters in Brussels. Upon retirement in 2011, he remained in Brussels as the director of NATO’s battlefield intelligence sharing enterprise until 2014. Upon return to Canada, he joined other, like-minded Veterans, to try to help fellow-Veterans of his era and younger, and their families, particularly those suffering from mental health issues.

Richard Kopelman serves as CEO and managing partner of Aprio, LLP, a nationally-recognized, top 50 CPA-led business advisory firm. In 2017, Richard championed an industry-leading rebrand that aligns the firm around a passion for guiding clients to what’s next. Richard has directed Aprio’s combination with more than twelve business concerns over the past four years growing Aprio from one office to now five regions. This has been accompanied by an award winning culture that was ranked 8th in diversity in the 2020 Vault Accounting survey. “We invest in our clients’ success by investing in our own,” Aprio’s mission, grew from Richard’s personal mission as the firm’s leader. Richard recognizes the importance of a strong, team-oriented culture where opportunity exists for all team members and impacts all clients. He is an active member of the Downtown Atlanta Rotary, Vistage International and a variety of domestic and international charitable organizations.